The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Enhancing the Target and Biomarker Discovery Efforts of the AMP-AD and M2OVE-AD Consortia (R01)
This funding opportunity invites applications that would enhance the goals and deliverables of the AMP-AD Target Discovery and Preclinical Validation and M2OVE Consortia by maximizing the usability of the data and analytical results generated by these programs, seizing opportunities for additional target and biomarker discovery, and accelerating the validation of the novel targets and biomarkers being discovered within the AMP-AD and M2OVE-AD Consortia.
Application Due Date(s): February 3, 2017
RFA-AG-17-054 Expiration Date February 4, 2017
Annual direct costs are capped at $750,000.
The total project period for an application submitted in response to this FOA may not exceed 3 years.